Senti Bio Strengthens Leadership with Board Appointment Senti Biosciences has appointed Feng Hsiung to its Board of Directors, effective March 7, 2025. Hsiung, an experienced investment executive, will bring strategic insights to the company’s operations. This move comes alongside the issuance of 202,700 stock options to new employees, signaling efforts to align leadership and employee incentives with growth.12